SEARCH

SEARCH BY CITATION

References

  • Alin P., Danielson U. H. and Mannervik B. (1985) 4-Hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett. 179, 267270.
  • Brown G. K., Cromby C. H., Manning N. J. and Pollitt R. J. (1987) Urinary organic acids in succinic semialdehyde dehydrogenase deficiency: evidence of alpha-oxidation of 4–hydroxybutyric acid, interaction of succinic semialdehyde with pyruvate dehydrogenase and possible secondary inhibition of mitochondrial beta-oxidation. J. Inherit. Metab. Dis. 10, 367375.
  • Chambliss K. L. and Gibson K. M. (1992) Succinic semialdehyde dehydrogenase from mammalian brain: subunit analysis using polyclonal antiserum. Int. J. Biochem. 24, 14931499.
  • Chambliss K. L., Caudle D. L., Hinson D. D., Moomaw C. R., Slaughter C. A., Jakobs C. and Gibson K. M. (1995) Molecular cloning of the mature NAD(+)-dependent succinic semialdehyde dehydrogenase from rat and human. cDNA isolation, evolutionary homology, and tissue expression. J. Biol. Chem. 270, 461467.
  • Dockham P. A., Lee M. O. and Sladek N. E. (1992) Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmacol. 43, 24532469.
  • Esterbauer H., Schaur R. and Zollner H. (1991) Chemistry and Biochemistry of 4-hydroxynonenal, malondialdehyde, and related aldehydes. Free Radic. Biol. Med. 11, 81128.
  • Gibson K. M., Hoffmann G. F., Hodson A. K., Bottiglieri T. and Jakobs C. (1998) 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 29, 1422.
  • Gibson K. M., Schor D. S., Gupta M., Guerand W. S., Senephansiri H., Burlingame T. G., Bartels H., Hogema B. M., Bottiglieri T., Froestl W., Snead O. C., Grompe M. and Jakobs C. (2002) Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase. J. Neurochem. 81, 7179.
  • Hogema B. M., Gupta M., Senephansiri H., Burlingame T. G., Taylor M., Jakobs C., Schutgens R. B., Froestl W., Snead O. C., Diaz-Arrastia R., Bottiglieri T., Grompe M. and Gibson K. M. (2001) Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat. Genet. 29, 212216.
  • Kamino K., Nagasaka K., Imagawa M., Yamamoto H., Yoneda H., Ueki A., Kitamura S., Namekata K., Miki T. and Ohta S. (2000) Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem. Biophys. Res. Commun. 273, 192196.
  • Kang T. C., Park S. K., Hwang I. K., An S. J., Choi S. Y., Cho S. W. and Won M. H. (2002) Spatial and temporal alterations in the GABA shunt in the gerbil hippocampus following transient ischemia. Brain Res. 944, 1018.
  • Lauderback C. M., Hackett J. M., Huang F. F., Keller J. N., Szweda L. I., Markesbery W. R. and Butterfield D. A. (2001) The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1–42. J. Neurochem. 78, 413416.
  • Laurent A., Perdu-Durand E., Alary J., Debrauwer L. and Cravedi J. P. (2000) Metabolism of 4-hydroxynonenal, a cytotoxic product of lipid peroxidation, in rat precision-cut liver slices. Toxicol. Lett. 114, 203214.
  • Lipsky J. J., Shen M. L. and Naylor S. (2001) Overview: in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites. Chem. Biol. Interact. 130–132, 8191.
  • Markesbery W. R. and Lovell M. A. (1998) Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 19, 3336.
  • Mattson M. P., Fu W., Waeg G. and Uchida K. (1997) 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. Neuroreport 8, 22752281.
  • McKracken E., Graham D. I., Nilsen M., Stewart J., Nicoll J. A. and Horsburgh K. (2001) 4-Hydroxynonenal immunoreactivity is increased in human hippocampus after global ischemia. Brain Pathol. 11, 414421.
  • Mitchell D. and Petersen D. (1987) The oxidation of a,b,unsaturated aldehydic products in lipid peroxidation by rat liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 87, 403410.
  • Montine K. S., Kim P. J., Olson S. J., Markesbery W. R. and Montine T.  J. (1997a) 4-Hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease. J. Neuropathol. Exp. Neurol. 56, 866871.
  • Montine K. S., Olson S. J., Amarnath V., Whetsell W. O. Jr, Graham D. G. and Montine T. J. (1997b) Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150, 437443.
  • Murphy T., Amarnath V. and Picklo M. J. (2003a) Oxidation of 4-hydroxynonenal in rat brain slices. Chem. Biol. Interact. 143–144, 101105.
  • Murphy T. C., Amarnath V. and Picklo M. S. (2003b) Mitochondrial oxidation of 4-hydroxynonenal in rat cerebral cortex. J. Neurochem. 84, 13131321.
  • Neely M. D., Sidell K. R., Graham D. G. and Montine T. J. (1999) The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules, and modifies cellular tubulin. J. Neurochem. 72, 23232333.
  • Nguyen E. and Picklo M. J. (2003) Inhibition of succinic semialdehyde dehydrogenase activity by alkenal products of lipid peroxidation. Biochim. Biophys. Acta 1637, 107112.
  • O'Connor T., Ireland L. S., Harrison D. J. and Hayes J. D. (1999) Major differences exist in the function and tissue-specific expression of human aflatoxin B1 aldehyde reductase and the principal human aldo-keto reductase AKR1 family members. Biochem. J. 343, 487504.
  • Ohsawa I., Nishimaki K., Yasuda C., Kamino K. and Ohta S. (2003) Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J. Neurochem. 84, 11101117.
  • Pettersson H. and Tottmar O. (1982) Inhibition of aldehyde dehydrogenases in rat brain and liver by disulfiram and coprine. J. Neurochem. 39, 628634.
  • Picklo M. J., Olson S. J., Markesbery W. R. and Montine T. J. (2001) Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 686695.
  • Picklo M. J., Montine T. J., Amarnath V. and Neely M. D. (2002) Carbonyl toxicology and Alzheimer's disease. Toxicol. Appl. Pharmacol. 184, 187197.
  • Schneider C., Tallman K. A., Porter N. A. and Brash A. R. (2001) Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J. Biol. Chem. 276, 2083120838.
  • Sellin S., Holmquist B., Mannervik B. and Vallee B. (1991) Oxidation and reduction of 4-hydroxyalkenals catalyzed by isozymes of human alcohol dehydrogenase. Biochemistry 30, 25142518.
  • Sidell K. R., Montine K. S., Picklo M. J. Sr, Olsen S. J., Amarnath V. and Montine T. J. (2003) Mercapturate metabolism of 4-hydroxy-2-nonenal in rat and human cerebrum. J. Neuropathol. Exp. Neurol. 62, 146153.
  • Srivastava S., Chandra A., Bhatnagar A., Srivastava S. K. and Ansari N. H. (1995) Lipid peroxidation product, 4-hydroxynonenal and its conjugate with GSH are excellent substrates of bovine lens aldose reductase. Biochem. Biophys. Res. Commun. 217, 741746.
  • Staub R. E., Quistad G. B. and Casida J. E. (1998) Mechanism for benomyl action as a mitochondrial aldehyde dehydrogenase inhibitor in mice. Chem. Res. Toxicol. 11, 535543.
  • Tank A. W., Weiner H. and Thurman J. A. (1981) Enzymology and subcellular localization of aldehyde oxidation in rat liver: oxidation of 3,4-dihydroxyphenylacetaldehyde derived from dopamine to 3,4-dihydroxyphenylacetic acid. Biochem. Pharmacol. 30, 32653275.
  • Wang X., Sheikh S., Saigal D., Robinson L. and Weiner H. (1996) Heterotetramers of human liver mitochondrial (class 2) aldehyde dehydrogenase expressed in Escherichia coli. A model to study the heterotetramers expected to be found in Oriental people. J. Biol. Chem. 271, 3117231178.
  • Weiner H. and Ardelt B. (1984) Ditribution and properties of aldehdye dehydrogenase in regions of rat brain. J. Neurochem. 42, 109115.
  • Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. and Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 26962701.